Selective 5-lipoxygenase inhibition in ulcerative colitis
- 1 March 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 335 (8691), 683-685
- https://doi.org/10.1016/0140-6736(90)90803-d
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.Gut, 1987
- Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acidDigestive Diseases and Sciences, 1987
- Eicosanoids as bioregulators in clinical medicineThe American Journal of Medicine, 1985
- Comparison of radioimmunological determinations with gas chromatography mass spectrometry dosage. A study of PGE2 and PGF2α in gastrointestinal fluidsJournal of Mass Spectrometry, 1983
- Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitisBiochemical Pharmacology, 1983
- Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.Journal of Clinical Investigation, 1982
- Identification of the C(6)-S-conjugate of leukotriene a with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activityBiochemical and Biophysical Research Communications, 1980
- Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoidsNature, 1980
- Leukotriene B: a potential mediator of inflammationJournal of Pharmacy and Pharmacology, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980